Filing Details
- Accession Number:
- 0001209191-15-052073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-10 20:38:36
- Reporting Period:
- 2015-06-08
- Filing Date:
- 2015-06-10
- Accepted Time:
- 2015-06-10 20:38:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1373707 | Tetraphase Pharmaceuticals Inc | TTPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1509643 | Craig John Thompson | 480 Arsenal St Suite 110 Watertown MA 02472 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-08 | 22,499 | $14.45 | 22,842 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-08 | 11,862 | $43.50 | 10,980 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-08 | 10,637 | $43.00 | 343 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-06-08 | 22,499 | $0.00 | 22,499 | $14.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
197,501 | 2024-02-02 | No | 4 | M | Direct |
Footnotes
- This option vested as to 20% of the shares on February 3, 2014 and another 20% on February 3, 2015 and further vests as to 5% of the shares at the end of each successive three-month period thereafter until February 3, 2018.